Zakaria I. Ganiyu

FDA investigator

Appears on 5 documents from 2016 to 2018, mostly at sites in New Jersey. Most often cites control of microbiological contamination (21 CFR 211.113).

5
Documents on file
3.5
Observations per 483
2016
First seen
2018
Most recent

What they cite most

From 14 observations

Activity by year

2016: 2, 2017: 2, 2018: 1

Where

New Jersey 4 · Maryland 1

Is Zakaria I. Ganiyu coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

5 documents, newest first
FirmOpen
483 Cape DrugsJan 22, 2018 · Annapolis, Maryland
483 QuVa Pharma, Inc.Nov 30, 2017 · Bloomsbury, New Jersey
483 Ideal Specialty Apothecary, Inc. dba Ideal PharmacySep 29, 2017 · Union, New Jersey
483 Sewaren Innovative Pharmaceutical Packaging dba SIPPJul 19, 2016 · Avenel, New Jersey
EIR Prinston Pharmaceutical Inc.May 2, 2016 · Cranbury, New Jersey

About this profile

What does Zakaria I. Ganiyu inspect?

Zakaria I. Ganiyu appears on 5 documents on file covering 5 sites, mostly in New Jersey.

What do they cite most often?

21 CFR 211.113 (control of microbiological contamination), followed by 21 CFR 211.46 and 21 CFR 211.67.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Zakaria I. Ganiyu is dated Jan 22, 2018.